News & Blogs

Werfen Introduces NanoTYPE® HLA-11 Plus — First RUO HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes

Werfen, a global leader in specialized diagnostics, announced the launch of NanoTYPE® HLA-11 Plus, a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes. This new addition to Werfen’s […]

ImmuLINK® Panel ID Algorithm is NOW LAUNCHED!

Are you stressed about inspections, staff adhering to SOPs and maintaining competency with antibody identification workups? Do risks currently exist for clerical errors or oversights in your laboratory? Antibody identification send outs blowing your budget? Empower your staff, reduce stress, […]

Werfen acquires Omixon

Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for […]

NEW and Definitely Improved!

You deserve exceptional service/support and our NEW Customer Center is a testament to our commitment to your satisfaction. This innovative platform serves as a hub where you can access a wide range of resources, tools, and services to enhance your […]

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]